Leaflet LEUKOSCAN 0.31mg powder for solution for injection
Indicated for: diagnostic imaging of bone infection/inflammation; suspected osteomyelitis
Route of administration: injectable
Substance: sulesomab (radiopharmaceutical diagnostic agent)
ATC: V09HA04 (Various | Inflammation and infection detection | Technetium (99mtc) compounds)
Risk of severe allergic reaction. Seek urgent medical help if serious symptoms occur.
This medicine is subject to additional monitoring.
Use during breastfeeding only on medical advice.
Use during pregnancy only on medical advice.
Sulesomab is a radiolabeled monoclonal antibody used in medical imaging for the diagnosis of bone infections and other inflammations. It binds to receptors on the surface of leukocytes, allowing the localization of infection or inflammation sites through scanning.
The medication is administered intravenously, as directed by a doctor, prior to the scan. It is important for patients to be monitored to prevent adverse reactions.
Patients should be aware of potential side effects, such as injection site reactions, fever, or allergic reactions. It is important to inform the doctor of any unusual symptoms.
Common side effects include injection site reactions and fever. In rare cases, severe reactions such as serious allergic reactions may occur. Patients should be informed of these risks before the procedure.
General data about LEUKOSCAN 0.31mg
- Substance: sulesomab
- Date of latest medicines list: 01-07-2013
- Product code: W51532001
- Concentration: 0.31mg
- Pharmaceutical form: powder for solution for injection
- Quantity: 5
- Product type: Original
- Prescription status: S - Medicines dispensed with a restricted medical prescription, reserved for use in certain specialized fields.